NLS Pharmaceutics AG

NasdaqCM:NLSP

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

Location

Switzerland

Market Cap

USD 12.47 M

Share Price

USD 2.54

Avg Daily Volume

168,136

Change (1 day)

7.17%

Change (1 year)

-65.20%

Change (YTD)

20.38%

NLS Pharmaceutics AG Current Assets for the year ending December 31, 2023

NLS Pharmaceutics AG Current Assets is NA for the year ending December 31, 2023. Current assets are assets that are expected to be converted into cash or used within one year.

NLS Pharmaceutics AG Current Assets for the year ending December 31, 2020 was USD 196.71 K, a -48.47% change year over year.
NLS Pharmaceutics AG Current Assets for the year ending December 31, 2019 was USD 381.75 K.

Quarterly
Annual
TTM

From:

To:

Zoom:

1Y
3Y
5Y
10Y
15Y
20Y
Max

Key data

Date	Current Assets	Property, Plant, Equipment (Net)	Total Assets	Accounts Payable

NasdaqCM: NLSP

NLS Pharmaceutics AG

CEO	Mr. Alexander Zwyer M.B.A.
IPO Date	Jan. 29, 2021
Location	Switzerland
Headquarters	The Circle 6
Employees	6
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Clinical Trials

Description

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company was incorporated in 2015 and is based in Zurich, Switzerland.

Similar companies

AbbVie Inc.

USD 186.79

0.76%

Novo Nordisk A/S

USD 67.40

-0.61%

Roche Holding AG

USD 346.81

1.67%

Abbott Laboratories

USD 133.67

-2.71%

Novartis AG

USD 119.96

1.87%

AstraZeneca PLC

USD 139.42

-0.41%

Merck & Co., Inc.

USD 78.83

-1.05%

Amgen Inc.

USD 279.11

-0.44%

Pfizer Inc.

USD 24.24

-0.08%

Gilead Sciences, Inc.

USD 107.62

1.59%

Sanofi

USD 96.29

0.40%

Vertex Pharmaceuticals Incorporated

USD 443.40

-0.54%

Bristol-Myers Squibb Company

USD 46.65

-0.06%

Chugai Pharmaceutical Co., Ltd.

USD 52.04

-0.89%

GSK plc

USD 19.17

0.64%

CSL Limited

USD 154.14

-1.86%

Regeneron Pharmaceuticals, Inc.

USD 521.00

0.14%

MERCK Kommanditgesellschaft auf Aktien

USD 130.63

1.54%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.21

-0.69%

Takeda Pharmaceutical Company Limited

USD 30.27

0.35%

Alnylam Pharmaceuticals, Inc.

USD 318.25

-1.15%

UCB SA

USD 197.49

0.30%

GE HealthCare Technologies Inc.

USD 74.86

2.90%

Bayer AG

USD 30.75

-0.14%

WuXi AppTec Co., Ltd.

USD 9.61

-2.55%

Celltrion, Inc.

USD 117.59

0.22%

Laboratory Corporation of America Holdings

USD 256.98

-0.66%

Hansoh Pharmaceutical Group Company Limited

USD 3.70

-0.14%

Royalty Pharma plc

USD 35.27

-1.78%

Insmed Incorporated

USD 101.74

-2.97%

Biogen Inc.

USD 126.92

-0.31%

Astellas Pharma Inc.

USD 9.70

1.17%

Innovent Biologics, Inc.

USD 9.80

-2.13%

Summit Therapeutics Inc.

USD 21.32

0.24%

Shionogi & Co., Ltd.

USD 17.52

-0.59%

Genmab A/S

USD 206.84

0.92%

Neurocrine Biosciences, Inc.

USD 126.71

-0.84%

Torrent Pharmaceuticals Limited

USD 37.60

0.25%

Exelixis, Inc.

USD 43.09

-1.01%

Regencell Bioscience Holdings Limited

USD 20.19

-7.09%

Mankind Pharma Limited

USD 26.88

0.15%

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.53

0.36%

Akeso, Inc.

USD 11.66

-3.50%

BioMarin Pharmaceutical Inc.

USD 54.10

-0.07%

Ascendis Pharma A/S

USD 172.95

-0.03%

Lupin Limited

USD 22.50

0.04%

Swedish Orphan Biovitrum AB (publ)

USD 29.13

0.10%

Ipsen S.A.

USD 120.27

0.45%

Huadong Medicine Co., Ltd

USD 5.62

0.38%

StockViz Staff

June 27, 2025

Any question? Send us an email